LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.

Wang, Rong / Wei, Jinlai / Zhang, Shouru / Wu, Xingye / Guo, Jinbao / Liu, Maoxi / Du, Kunli / Xu, Jun / Peng, Linglong / Lv, Zhenbing / You, Wenxian / Xiong, Yongfu / Fu, Zhongxue

Oncotarget

2016  Volume 7, Issue 52, Page(s) 86816–86828

Abstract: ... mice. Taken together, colon CSCs overexpress Prdx2, which promotes their stem cell properties via ... Redox status is a critical factor in the maintenance of CSCs, and the antioxidant enzyme Peroxiredoxin 2 ... signaling pathway. Finally, knockdown of Prdx2 in CD133+ cells reduced the volume of xenograft tumors in BALB/c-nu ...

Abstract Cancer stem cells (CSCs) are a key target for reducing tumor growth, metastasis, and recurrence. Redox status is a critical factor in the maintenance of CSCs, and the antioxidant enzyme Peroxiredoxin 2 (Prdx2) plays an important role in the development of colon cancer. Therefore, we investigated the contribution of Prdx2 to the maintenance of stemness of colon CSCs. Here, we used short-hairpin RNAs and a Prdx2-overexpression vector to determine the effects of Prdx2. We demonstrated that knockdown of Prdx2 reduced the self-renewal and sphere formation and resulted in increased 5-FU-induced apoptosis in human colon CSCs. Prdx2 overexpression induced reversion of the self-renewal and sphere formation. Furthermore, the effects of Prdx2 resulted in an altered expression of stemness associated with the Hh/Gli1 signaling pathway. Finally, knockdown of Prdx2 in CD133+ cells reduced the volume of xenograft tumors in BALB/c-nu mice. Taken together, colon CSCs overexpress Prdx2, which promotes their stem cell properties via the Hh/Gli1 signaling pathway. The results suggest that Prdx2 may be an effective therapeutic target for the elimination of CSCs in colorectal cancer.
MeSH term(s) Animals ; Antimetabolites, Antineoplastic/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; Cell Line, Tumor ; Cell Self Renewal/drug effects ; Colonic Neoplasms/genetics ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/therapy ; Female ; Fluorouracil/pharmacology ; HCT116 Cells ; HT29 Cells ; Hedgehog Proteins/metabolism ; Humans ; Mice, Inbred BALB C ; Mice, Nude ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; Peroxiredoxins/genetics ; Peroxiredoxins/metabolism ; Phenotype ; RNA Interference ; RNAi Therapeutics/methods ; Signal Transduction ; Spheroids, Cellular/drug effects ; Spheroids, Cellular/metabolism ; Xenograft Model Antitumor Assays/methods
Chemical Substances Antimetabolites, Antineoplastic ; Hedgehog Proteins ; Peroxiredoxins (EC 1.11.1.15) ; Fluorouracil (U3P01618RT)
Language English
Publishing date 2016-11-23
Publishing country United States
Document type Journal Article
ZDB-ID 2560162-3
ISSN 1949-2553 ; 1949-2553
ISSN (online) 1949-2553
ISSN 1949-2553
DOI 10.18632/oncotarget.13559
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top